Colon Cancer Home > Erbitux
Erbitux can be given alone or in combination with other drugs to treat advanced colorectal cancer as well as squamous cell carcinoma of the head and neck. It is given by infusion into a vein over a period of one to two hours. Side effects are possible and will likely include injection site reactions, fatigue, and diarrhea.
What Is Erbitux?Erbitux® (cetuximab) is a prescription medication approved for the treatment of certain types of cancer. Specifically, the medication is used to treat certain people who have:
- Squamous cell carcinoma of the head and neck
- Advanced colorectal cancer (cancer of the colon and rectum) that expresses a protein called epidermal growth factor receptor (EGFR).